Applicant, as named in the Orange Book

Medexus

Next listed expiry: Rasuvo on 1 Jun 2029. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Rasuvo · 9 strengths methotrexate	methotrexate	205776	1 Jun 2029	patent, carve-out possible
Grafapex · 2 strengths treosulfan	treosulfan	214759	21 Jan 2032	exclusivity

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.